Cetrelimab ELISA Kit
Product Specifications
Background
Cetrelimab (JNJ-63723283) is an IgG4, anti-programmed cell death protein-1 (PD-1) antibody. Here we present updated results from an ongoing phase 1/2 study of cetrelimab in patients (pts) with advanced or refractory solid cancers.
Specifications
Cetrelimab
Product Name Alternative
JNJ-63723283, CAS: 2050478-92-5
Detection Method
Colorimetric
Assay Type
Quantitative
Sample Type
Plasma, Serum
Detection Range
0.31-5 μg/mL
Recovery
80-120%
Sensitivity
0.156 μg/ml
Shipping Conditions
2-8 °C
Storage Conditions
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Notes
For Research Use Only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB2503-100 1x 100 µL
CD73 (Immuno-Oncology Target) (NT5E/2503), 0.2mg/mL
Sign In for Pricing
View Details 
BNCB2349-100 1x 100 µL
MUC16 / CA125 (Ovarian Carcinoma Marker) (OCA125/2349R), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
